(Q41362615)

29 September 2017

1 reference

title

Serum and urine albumin: a progress report on their measurement and clinical significance (English)

1 reference

29 September 2017

Doumas BT

1

1 reference

29 September 2017

Peters T Jr

series ordinal

2

1 reference

29 September 2017

language of work or name

1 reference

1 February 1997

1 reference

29 September 2017

1 reference

29 September 2017

volume

258

1 reference

29 September 2017

issue

1

1 reference

29 September 2017

page(s)

3-20

1 reference

Albumin standards and the measurement of serum albumin with bromcresol green

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Characterization, primary structure, and evolution of lamprey plasma albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

A point mutation in the human serum albumin gene results in familial dysalbuminaemic hyperthyroxinaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Predictors of survival in continuous ambulatory peritoneal dialysis patients: the importance of prealbumin and other nutritional and metabolic markers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Serum albumin and mortality after renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Serum albumin level and physical disability as predictors of mortality in older persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

A simple method for the rapid determination of serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

The determination of albumin in human blood plasma and serum; a method based on the interaction of albumin with an anionic dye-2(4'-hydroxybenzeneazo) benzoic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Measurement of serum albumin by the HABA-dye technique: a study of the effect of free and conjugated bilirubin, of bile acids and of certain drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

The measurement of albumin in serum and plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

An assessment of the suitability of bromocresol green for the determination of serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

A comparison of Bromcresol Green and immunoprecipitation methods for the determination of serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

An Evaluation of the Overestimation of Serum Albumin by Bromcresol Green

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

A study of the interaction of bromocresol green with isolated serum globulin fractions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Automated stopped-flow analyser in clinical chemistry: determination of albumin with bromcresol green and purple.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Albumin analysis in serum of haemodialysis patients: discrepancies between bromocresol purple, bromocresol green and electroimmunoassay.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Bromcresol purple method for serum albumin gives falsely low values in patients with renal insufficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Isolation and characterization of an endogenous drug-binding inhibitor present in uremic serum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Underestimation of serum albumin by the bromcresol purple method and a major endogenous ligand in uremia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Serum albumin by dye-binding: bromocresol green or bromocresol purple? The case for conservatism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Canadian Hemodialysis Morbidity Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Serum albumin concentration-related Health Care Financing Administration quality assurance criterion is method-dependent: revision is necessary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Solid-phase fluoroimmunoassay of human albumin in biological fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Non-separation fluoroimmunoassay of human albumin in biological fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Hypertension and diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Reduction of urinary albumin excretion after 4 years of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus. The Oslo Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

A solid phase fluorescent immunoassay for the measurement of human urinary albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Quantification of albumin in urine by a new method: zone immuno-electrophoresis assay (ZIA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Microalbuminuria. Invalidity of simple concentration-based screening tests for early nephropathy due to urinary volumes of diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Single-void urine samples can be used to estimate quantitative microalbuminuria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Assessment of risk of overt nephropathy in diabetic patients from albumin excretion in untimed urine specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Comparison of albumin excretion rate obtained with different times of collection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Microalbuminuria: An Early Marker of Renal Involvement in Diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Urinary albumin excretion. Timed urine collections advisable

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Microalbuminuria in diabetes mellitus: review and recommendations for the measurement of albumin in urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

The variability of overnight urinary albumin excretion in insulin-dependent diabetic and normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

Microalbuminuria in diabetes: a population study of the prevalence and an assessment of three screening tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2896%2906446-7

10.1016/S0009-8981(96)06446-7

7 January 2021

Identifiers

DOI

1 reference

29 September 2017

1 reference